by Portfolio Grader | May 10, 2013 11:16 am
This week, five Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
TherapeuticsMD Inc’s (AMEX:TXMD) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). In Portfolio Grader’s specific subcategories of Earnings Momentum and Sales Growth, TXMD also gets A’s. TherapeuticsMD operates as a womens healthcare product company in the United States. For more information, get Portfolio Grader’s complete analysis of TXMD stock.
Johnson & Johnson (NYSE:JNJ) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The stock has a dividend yield of 2.4%. For more information, get Portfolio Grader’s complete analysis of JNJ stock.
Bristol-Myers Squibb (NYSE:BMY) improves from a C to a B rating this week. Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock.
The rating of Watson Pharmaceuticals (NYSE:WPI) moves up this week, rising from a B to an A. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock.
Repros Therapeutics (NASDAQ:RPRX) earns an A this week, jumping up from last week’s grade of B. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. For more information, get Portfolio Grader’s complete analysis of RPRX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
Source URL: https://investorplace.com/2013/05/5-pharmaceutical-stocks-to-buy-now-txmd-jnj-bmy/
Short URL: http://invstplc.com/1nAAhKl
Copyright ©2017 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.